# Daneng Li

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/daneng-li/

## Facts

| Field | Value |
| --- | --- |
| Citations | 17,648 |
| Field | Hepatocellular Carcinoma Treatment and Prognosis |
| h-index | 34 |
| i10-index | 85 |
| Last Known Institution | City Of Hope National Medical Center |
| OpenAlex ID | https://openalex.org/A5037942451 |
| ORCID iD | https://orcid.org/0000-0001-5330-7522 |
| Works | 233 |

## Researcher papers

- [Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial](https://scholariq.org/papers/pembrolizumab-in-patients-with-advanced-hepatocellular-carcinoma-previously/)

## Researcher topics

- [Hepatocellular Carcinoma Treatment and Prognosis](https://scholariq.org/topics/hepatocellular-carcinoma-treatment-and-prognosis/)
- [Cholangiocarcinoma and Gallbladder Cancer Studies](https://scholariq.org/topics/cholangiocarcinoma-and-gallbladder-cancer-studies/)
- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)
- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

## Researcher university

- [City Of Hope National Medical Center](https://scholariq.org/institutions/city-of-hope-national-medical-center/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.